News

Targanta is seeking approval of intravenous oritavancin in the EU for the treatment of complicated skin and soft tissue infections (cSSTI) caused by gram-positive bacteria, including methicillin-resistant Staphylococcus

Otsuka’s Tolvaptan is an investigational selective antagonist of the vasopressin V2 receptor, which is located predominantly in the kidney and plays a role in the regulation of fluid

Renato would then utilize Optimal Health Clinic’s infrastructure to introduce early detection diagnostic technologies. Renato considers this location to be an excellent launching model for the company’s future

Dr Nissenson is a former president of the Renal Physicians Association and serves on the RPA board of directors as a special advisor to the current president. Kent

The study is a three-arm, randomized trial which will enroll up to 180 patients at cancer centers in North America and Europe. Charles Craddock, professor of haemato-oncology at

The collaboration will leverage microRNAs’s significant potential as highly sensitive and specific biomarkers, to develop a wide range of diagnostic and prognostic tests. This is the company’s first

The mutual goal is to provide the ‘picks and shovels’ for scientists mining the stem cell field for therapeutics in the emerging field of regenerative medicine and pharmaceutical

As announced previously, the OVA1 prospective clinical trial met its primary endpoints, indicating that the test is capable of stratifying women with pelvic masses into high- and low-risk

Acuvue Oasys for astigmatism combines the accelerated stabilization design (ASD) technology of Acuvue Advance brand contact lenses for astigmatism, with senofilcon A, the new generation silicone hydrogel material